Sector Gamma AS’s Regeneron Pharmaceuticals REGN Stock Holding History

Sector Gamma AS’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.84M	Buy	+15,780	New	+$10.7M	2.13%	19
2026 Q1	–	Sell	-7,165	Closed	-$5.53M	–	46
2025 Q4	$5.53M	Buy	+7,165	New	+$4.87M	1.26%	26
2021 Q3	–	Sell	-4,876	Closed	-$2.72M	–	38
2021 Q2	$2.72M	Hold	4,876	–	–	0.48%	36
2021 Q1	$2.31M	Buy	+4,876	New	+$2.37M	0.42%	32
2020 Q1	–	Sell	-28,458	Closed	-$10.7M	–	35
2019 Q4	$10.7M	Sell	28,458 -47,377	-62%	-$15.9M	1.71%	23
2019 Q3	$21M	Buy	75,835 +18,200	+32%	+$5.39M	3.55%	9
2019 Q2	$18M	Buy	+57,635	New	+$19.2M	2.9%	13
2018 Q3	–	Sell	-28,500	Closed	-$9.83M	–	35
2018 Q2	$9.83M	Buy	+28,500	New	+$8.91M	1.63%	19

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sector Gamma AS's REGN Position: Q2 2026 in Review

Sector Gamma AS opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 15,780 shares worth $9.84M. The stake represents 2.13% of the portfolio and ranks #19 among its holdings. This is a return to the name: Sector Gamma AS previously reported a position in REGN as recently as Q4 2025.

Sector Gamma AS first reported a position in REGN in Q2 2018 and has held it in 8 quarters since. The position peaked at $21M in Q3 2019. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Sector Gamma AS held 15,780 shares of Regeneron Pharmaceuticals worth $9.84M as of Q2 2026.
Regeneron Pharmaceuticals was a new Sector Gamma AS position in Q2 2026.
Regeneron Pharmaceuticals made up 2.13% of Sector Gamma AS's portfolio in Q2 2026, its #19 holding.
Sector Gamma AS first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 8 quarters since.
Sector Gamma AS's Regeneron Pharmaceuticals position peaked at $21M in Q3 2019.
1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Sector Gamma AS's 13F filing for Q2 2026, filed 12 Aug 2026.